Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people worldwide, and their prevalence is only increasing, according to the World Health Organization.
Digital health is unlocking new avenues for innovation across life sciences, and industry leaders are keen to tap into the potential of this burgeoning area.
In the year since the UK went into its first lockdown to limit the spread of COVID-19 the country’s health service has undergone an unprecedented digital transformation.
The ubiquity of digital technology allows pharma reps to communicate with healthcare professionals (HCPs) through their preferred channels, making a positive difference to engagement, relat
Pharma is playing catch-up with digital technology – but in this age of big data and AI, there are benefits to adopting it to help engage with clients.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
